Positron Emission Tomography (PET) Scanner Market Introduction and Overview
According to SPER Market Research, the Global Positron Emission Tomography (PET) Scanner Market is estimated to reach USD 3.87 billion by 2033 with a CAGR of 3.86%.
The report includes an in-depth analysis of the Global Positron Emission Tomography (PET) Scanner Market, including market size and trends, product mix, applications, and supplier analysis. A medical imaging tool called a Positron Emission Tomography (PET) scanner enables physicians to view bodily metabolic and functional processes, frequently at the cellular level. When a tiny quantity of a radioactive material, usually a radiotracer, is injected into the body, it detects pairs of gamma rays that are released. This material is typically a kind of glucose or similar decaying molecule that releases positrons.
- In June 2024, enhanced whole-body scanning via magnifying PET (AWSM-PET), a recently introduced technique, demonstrated notable improvements in system sensitivity and picture quality for clinical whole-body PET/CT imaging.
- The groundbreaking Mobile Dedicated Cardiac PET/CT Trailer, which CDL Nuclear Technologies unveiled in April 2024, will revolutionize cardiac treatment by delivering cutting-edge PET/CT imaging services straight to medical facilities on their schedule.
Market Opportunities and Challenges
Opportunities- A growing need for PET analysis in radiopharmaceuticals, a noticeable move towards image-guided therapies, and improvements in PET imaging technology for complex diagnostic applications and cancer are some of the main drivers. It is anticipated that incorporating these advances would increase the use of PET scanners in a variety of medical specialties as the healthcare industry develops. The market is growing as a result of increased government funding for expediting drug development procedures while maintaining patient safety. Utilizing real-world data in clinical trials, for example, is encouraged by the FDA's Real-World Evidence (RWE) program and can result in more effective research designs and speedier approvals.
Challenges- PET scanners have been proven to be effective, however ongoing reimbursement reductions are impeding the market's expansion. Players' access to high-quality and reasonably priced diagnostic imaging services has been impacted by the global refusal of payment for these items, which has led to a decrease in outpatient traffic. Furthermore, Numerous obstacles prevent the market for Positron Emission Tomography (PET) scanners from expanding and becoming widely used. The high expense of PET scanners and their upkeep is one of the main obstacles, preventing many healthcare facilities, particularly those in poor nations, from having access to them. The radiotracers needed for imaging are expensive and have a limited shelf life, making it challenging to stock and administer effectively. The scanners themselves are also expensive to buy. The logistical complexity is further increased by the requirement for specialized facilities to handle and fabricate these radiotracers.
Market Competitive Landscape
The Global Positron Emission Tomography (PET) Scanner Market is highly consolidated. Some of the market key players are Canon Medical Systems, GE Healthcare, Kindsway Biotech, Koninklijke Philips N.V., Mediso Ltd., PerkinElmer, Positron, Shimadzu Corporation, and Siemens Healthineers AG.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Modality, By Application, By End Use |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe |
| Companies Covered | Canon Medical Systems, GE Healthcare, Kindsway Biotech, Koninklijke Philips N.V., Mediso Ltd., PerkinElmer, Positron, Shimadzu Corporation, and Siemens Healthineers AG. |
COVID-19 Impact on Global Positron Emission Tomography (PET) Scanner Market
The global Positron Emission Tomography (PET) scanner market was significantly impacted by the COVID-19 pandemic, which affected supply and demand in different geographical areas. The healthcare industry experienced significant disruptions in the early stages of the pandemic, such as a reduction in patient visits, a delay in elective medical treatments, and the reallocation of resources to combat the outbreak. The use of PET scanners for standard diagnostic processes, such as cancer diagnosis and neurological evaluations, consequently drastically decreased. Non-urgent imaging tests were frequently canceled or postponed as a result of healthcare facilities' attention being diverted to treating COVID-19 patients.
Key Target Audience
- Hospitals and Healthcare Institutions
- Diagnostic Imaging Centers
- Oncology Clinics
- Neurology Centers
- Research and Academic Institutions
- Pharmaceutical and Biotechnology Companies
- Government Healthcare Agencies
Our in-depth analysis of the Positron Emission Tomography (PET) Scanner Market includes the following segments:
| By Modality Outlook: | PET-CTPET-MRI |
| By Application: | OncologyCardiologyNeurology |
| By End Use: | HospitalsDiagnostic Imaging CentersAcademic & Research Institutes |
| By Region: | Asia-PacificEuropeMiddle East & AfricaNorth AmericaLatin America |
Key Topics Covered in the Report
- Global Positron Emission Tomography (PET) Scanner Market Size (FY’2024-FY’2033)
- Overview of Global Positron Emission Tomography (PET) Scanner Market
- Segmentation of Global Positron Emission Tomography (PET) Scanner Market By Modality (PET-CT, PET-MRI)
- Segmentation of Global Positron Emission Tomography (PET) Scanner Market By Application (Oncology, Cardiology, Neurology)
- Segmentation of Global Positron Emission Tomography (PET) Scanner Market By End User (Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes)
- Statistical Snap of Global Positron Emission Tomography (PET) Scanner Market
- Expansion Analysis of Global Positron Emission Tomography (PET) Scanner Market
- Problems and Obstacles in Global Positron Emission Tomography (PET) Scanner Market
- Competitive Landscape in the Global Positron Emission Tomography (PET) Scanner Market
- Impact of COVID-19 and Demonetization on Global Positron Emission Tomography (PET) Scanner Market
- Details on Current Investment in Global Positron Emission Tomography (PET) Scanner Market
- Competitive Analysis of Global Positron Emission Tomography (PET) Scanner Market
- Prominent Players in the Global Positron Emission Tomography (PET) Scanner Market
- SWOT Analysis of Global Positron Emission Tomography (PET) Scanner Market
- Global Positron Emission Tomography (PET) Scanner Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Positron Emission Tomography (PET) Scanner Market.
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Positron Emission Tomography (PET) Scanner Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Positron Emission Tomography (PET) Scanner Market
7. Global Positron Emission Tomography (PET) Scanner Market, By Modality Outlook (USD Million) 2020-2033
7.1. Global Positron Emission Tomography (PET) Scanner Market Size, Share and Forecast, By Modality Outlook, 2020-2026
7.2. Global Positron Emission Tomography (PET) Scanner Market Size, Share and Forecast, By Modality Outlook, 2027-2033
7.3. PET-CT
7.4. PET-MRI
8. Global Positron Emission Tomography (PET) Scanner Market, By Application (USD Million) 2020-2033
8.1. Global Positron Emission Tomography (PET) Scanner Market Size, Share and Forecast, By Therapeutic Areas, 2020-2026
8.2. Global Positron Emission Tomography (PET) Scanner Market Size, Share and Forecast, By Therapeutic Areas, 2027-2033
8.3. Oncology
8.4. Cardiology
8.5. Neurology
9. Global Positron Emission Tomography (PET) Scanner Market, By End Use (USD Million) 2020-2033
9.1. Global Positron Emission Tomography (PET) Scanner Market Size, Share and Forecast, By End User, 2020-2026
9.2. Global Positron Emission Tomography (PET) Scanner Market Size, Share and Forecast, By End User, 2027-2033
9.3. Hospitals
9.4. Diagnostic Imaging Centers
9.5. Academic & Research Institutes
10. Global Positron Emission Tomography (PET) Scanner Market Forecast, 2020-2033 (USD Million)
10.1. Global Positron Emission Tomography (PET) Scanner Market Size and Market Share
11. Global Positron Emission Tomography (PET) Scanner Market, By Region, 2020-2033 (USD Million)
11.1. Global Positron Emission Tomography (PET) Scanner Market Size and Market Share By Region (2020-2026)
11.2. Global Positron Emission Tomography (PET) Scanner Market Size and Market Share By Region (2027-2033)
11.3. Asia-Pacific
11.3.1. Australia
11.3.2. China
11.3.3. India
11.3.4. Japan
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific
11.4. Europe
11.4.1. France
11.4.2. Germany
11.4.3. Italy
11.4.4. Spain
11.4.5. United Kingdom
11.4.6. Rest of Europe
11.5. Middle East and Africa
11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates
11.5.3. Qatar
11.5.4. South Africa
11.5.5. Egypt
11.5.6. Morocco
11.5.7. Nigeria
11.5.8. Rest of Middle-East and Africa
11.6. North America
11.6.1. Canada
11.6.2. Mexico
11.6.3. United States
11.7. Latin America
11.7.1. Argentina
11.7.2. Brazil
11.7.3. Rest of Latin America
12. Company Profile
12.1. Canon Medical Systems
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. GE Healthcare
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Kindsway Biotech
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Koninklijke Phillips N.V.
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Mediso Ltd.
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. PerkinElmer
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Positron
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Shimadzu Corporation
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Siemens Healthineers AG
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
